Literature DB >> 35254924

Reductions In Hospitalizations Among Children Referred To A Primary Care-Based Medical-Legal Partnership.

Andrew F Beck1, Adrienne W Henize2, TingTing Qiu3, Bin Huang4, Yin Zhang5, Melissa D Klein6, Donita Parrish7, Elaine E Fink8, Robert S Kahn9.   

Abstract

Medical-legal partnerships integrate legal advocates into health care settings to address health-related social needs. However, their effect on health outcomes is unclear. This retrospective cohort study examined the effect of referral to a medical-legal partnership on hospitalization rates among urban, low-income children in Greater Cincinnati, Ohio, between 2012 and 2017. We compared 2,203 children referred to a pediatric primary care-based medical-legal partnership with 100 randomly selected control cohorts drawn from 34,235 children seen concurrently but not referred. We found that the median predicted hospitalization rate for children in the year after referral was 37.9 percent lower if children received the legal intervention than if they did not. We suspect that this decrease in hospitalizations was driven by the ability of legal advocates to address acute legal needs (for example, threat of eviction and public benefit denial) and, when possible, to confront root causes of ill health (for example, unhealthy housing conditions). Interventions such as those provided through a medical-legal partnership may be important components of integrated, value-based service delivery models.

Entities:  

Mesh:

Year:  2022        PMID: 35254924     DOI: 10.1377/hlthaff.2021.00905

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  1 in total

1.  Declining influenza vaccination rates in an underserved pediatric primary care center during the COVID-19 pandemic.

Authors:  Melissa E Day; Melissa Klein; Heidi Sucharew; Mary Carol Burkhardt; Allison Reyner; Destiney Giles; Andrew F Beck; Elizabeth P Schlaudecker
Journal:  Vaccine       Date:  2022-09-12       Impact factor: 4.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.